| HPV Workshop Schedule |
| 1:00 - 13:30 µî·Ï |
| 1:30 - 13:35 °³È¸»ç¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý ÀÌ»çÀå ÀÌȿǥ |
| |
|
Part I Recent Progress in HPV Work¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý ÁÂÀå ¸ñÁ¤Àº |
| 1:35 - 2:00 Negative margin after conization & the risk of persistent high-risk HPV infection |
| ¤ý¤ý¤ý°í·ÁÀÇ´ë ¼Û½ÂÈÆ |
| 2:00 - 2:25 Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics |
| ¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ýKRIBB À±µµ¿µ |
2:25 ~ 2:50 Polymorphism in the E6 gene of HPV 16 in the cervical tissues of Korean women |
| ¤ý¤ý¤ý ±¹¸²¾Ï¼¾ÅÍ °¼®¹ü |
| 2:50 ~ 3:15 Can HPV DNA testing substitute for cytology in the detection of high-grade cervical lesions? |
| ¤ý¤ý¤ý °í·ÁÀÇ´ë ÀÌÀç°ü |
| 3:15 ~ 3:40 ÈÞ½Ä |
| |
|
Part II Special lecture on HPV vaccine¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý ÁÂÀå ±èÀç¿í |
| 3:40 - 4:20 Cervarix¨Þ development update |
| ¤ý¤ý¤ý¤ý¤ý¤ýGSK ±è°æÈ£ |
| 4:20 - 4:50 Prospect of prophylactive HPV vaccine: Experiences from pediatrician |
| ¤ý¤ý¤ý¤ý¤ý¤ýÇѱ¹¼Ò¾Æ°¨¿°º´ÇÐȸ ȸÀå ¿À¼ºÈñ |
| |
| |
| |
| |
|
Part III Updated Review¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý¤ý ÁÂÀå ³²±Ã¼ºÀº |
| 4:50 - 5:10 Clinical guideline for the use of liquid-based cytology |
| ¤ý¤ý¤ý ÇѸ²ÀÇ´ë ¹Ú¿µÇÑ |
| 5:10 - 5:30 Clinical guideline for the use of HPV DNA test¤ý¤ý¤ý¼¿ïÀÇ´ë Àü¿ëŹ |
| |
| 5:30 - 5:35 Æóȸ |